Susan C. Modesitt, MD of University of Virginia Health System discusses the use of PARP inhibitors and their benefits towards treating women with ovarian cancer. This was recorded at the 2017 Society of Gynecologic Oncology (SGO)s Annual Meeting on Womens Cancer® in National Harbor, MD.
Data Suggest More Women with Ovarian Cancer Could Benefit from PARP Inhibitors
